Woźniczka Magdalena, Vogt Andrzej, Kufelnicki Aleksander
Department of Physical and Biocoordination Chemistry, Faculty of Pharmacy, Medical University of Łódź, Muszyńskiego 1, 90-151 Łódź, Poland.
Faculty of Chemistry, University of Wrocław, F. Joliot-Curie 14, 50-383 Wrocław, Poland.
Chem Cent J. 2016 Mar 31;10:14. doi: 10.1186/s13065-016-0160-5. eCollection 2016.
Heteroligand Co(II) complexes involving imidazole and selected bio-relevant L-α-amino acids of four different groups (aspartic acid, lysine, histidine and asparagine) were formed by using a polymeric, pseudo-tetrahedral, semi-conductive Co(II) complex with imidazole-[Co(imid)2]n as starting material. The coordination mode in the heteroligand complexes was unified to one imidazole in the axial position and one or two amino acid moieties in the appropriate remaining positions. The corresponding equilibrium models in aqueous solutions were fully correlated with the mass and charge balance equations, without any of the simplified assumptions used in earlier studies. Precise knowledge of equilibria under oxygen-free conditions would enable evaluation of the reversible oxygen uptake in the same Co(II)-amino acid-imidazole systems, which are known models of artificial blood-substituting agents.
Heteroligand complexes were formed as a result of proton exchange between the two imidazole molecules found in the [Co(imid)2]n polymer and two functional groups of the amino acid. Potentiometric titrations were confirmed by UV/Vis titrations of the respective combinations of amino acids and Co-imidazole. Formation of MLL' and ML2L' species was confirmed for asparagine and aspartic acid. For the two remaining amino acids, the accepted equilibrium models had to include species protonated at the side-chain amine group (as in the case of lysine: MLL'H, ML2L'H2, ML2L'H) or at the imidazole N1 (as in the case of histidine: MLL'H and two isomeric forms of ML2L'). Moreover, the Δlog10 β, log10 β stat, Δlog10 K, and log10 X parameters were used to compare the stability of the heteroligand complexes with their respective binary species. The large differences between the constant for the mixed-ligand complex and the constant based on statistical data Δlog10 β indicate that the heteroligand species are more stable than the binary ones. The parameter Δlog10 K, which describes the influence of the bonded primary ligand in the binary complex Co(II)(Himid) towards an incoming secondary ligand (L) forming a heteroligand complex, was negative for all the Amac ligands (except for histidine, which shows stacking interactions). This indicates that the mixed-ligand systems are less stable than the binary complexes with one molecule of imidazole or one molecule of amino acid, in contrast to Δlog10 β, which deals with binary complexes Co(II)(Himid)2 and Co(II)(AmacH-1)2 containing two ligand molecules. The high positive values of the log10 X disproportionation parameter were in good agreement with the results of the Δlog10 β calculations mentioned above.
The mixed-ligand MLL'-type complexes are formed at pH values above 4-6 (depending on the amino acid used), however, the so-called "active" ML2L'-type complexes, present in the equilibrium mixture and known to be capable of reversible dioxygen uptake, attain maximum share at a pH around nine. For all the amino acids involved, the greater the excess of amino acid, the lower the pH where the given heteroligand complex attains maximum share. The results of our equilibrium studies make it possible to evaluate the oxygenation constants in full accordance with the distribution of species in solution. Such calculations are needed to drive further investigations of artificial blood-substituting systems.
以聚合物、假四面体、半导体钴(Ⅱ)咪唑配合物[Co(imid)₂]ₙ为原料,合成了涉及咪唑以及四个不同组(天冬氨酸、赖氨酸、组氨酸和天冬酰胺)的特定生物相关L-α-氨基酸的异配体钴(Ⅱ)配合物。异配体配合物中的配位模式统一为轴向位置的一个咪唑以及其余适当位置的一个或两个氨基酸部分。水溶液中的相应平衡模型与质量和电荷平衡方程完全相关,没有使用早期研究中所做的任何简化假设。在无氧条件下对平衡的精确了解将有助于评估相同钴(Ⅱ)-氨基酸-咪唑体系中的可逆吸氧情况,这些体系是已知的人工血液替代品模型。
异配体配合物是由[Co(imid)₂]ₙ聚合物中存在的两个咪唑分子与氨基酸的两个官能团之间的质子交换形成的。通过氨基酸和钴-咪唑各自组合的紫外/可见滴定法证实了电位滴定法。对于天冬酰胺和天冬氨酸,证实形成了MLL'和ML₂L'物种。对于其余两种氨基酸,公认的平衡模型必须包括在侧链胺基团质子化的物种(如赖氨酸的情况:MLL'H、ML₂L'H₂、ML₂L'H)或在咪唑N1质子化的物种(如组氨酸的情况:MLL'H和ML₂L'的两种异构体形式)。此外,使用Δlog₁₀β、log₁₀βstat、Δlog₁₀K和log₁₀X参数来比较异配体配合物与其各自二元物种的稳定性。混合配体配合物的常数与基于统计数据的常数Δlog₁₀β之间的巨大差异表明异配体物种比二元物种更稳定。参数Δlog₁₀K描述了二元配合物Co(Ⅱ)(Himid)中键合的一级配体对形成异配体配合物的进入二级配体(L)的影响,对于所有的Amac配体(组氨酸除外,其显示出堆积相互作用)均为负值。这表明混合配体体系比含有一个咪唑分子或一个氨基酸分子的二元配合物稳定性更低,这与处理含有两个配体分子的二元配合物Co(Ⅱ)(Himid)₂和Co(Ⅱ)(AmacH⁻¹)₂的Δlog₁₀β相反。log₁₀X歧化参数的高正值与上述Δlog₁₀β计算结果高度一致。
混合配体MLL'-型配合物在pH值高于4 - 6时形成(取决于所使用的氨基酸),然而平衡混合物中存在的所谓“活性”ML₂L'-型配合物,已知其能够可逆地吸收双氧,在pH约为9时达到最大比例。对于所有涉及的氨基酸,氨基酸过量越多,给定异配体配合物达到最大比例时的pH值越低。我们的平衡研究结果使得能够根据溶液中物种的分布来全面评估氧合常数。这种计算对于推动人工血液替代系统的进一步研究是必要的。